-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ArLRknk0Qz1IrTFaMyZQHJVQ1P5QVoIcZ99Q3b5YZi9+aPbtoFQGPAQT4ihWcTrZ 8BoCc7WJAVn8Mvh+YWKr2Q== 0000950123-09-000840.txt : 20090120 0000950123-09-000840.hdr.sgml : 20090119 20090120114303 ACCESSION NUMBER: 0000950123-09-000840 CONFORMED SUBMISSION TYPE: 15-12G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20090120 DATE AS OF CHANGE: 20090120 EFFECTIVENESS DATE: 20090120 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENELABS TECHNOLOGIES INC /CA CENTRAL INDEX KEY: 0000874443 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943010150 STATE OF INCORPORATION: CA FISCAL YEAR END: 0131 FILING VALUES: FORM TYPE: 15-12G SEC ACT: 1934 Act SEC FILE NUMBER: 000-19222 FILM NUMBER: 09533431 BUSINESS ADDRESS: STREET 1: 505 PENOBSCOT DR CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 6503969500 MAIL ADDRESS: STREET 1: 505 PENOBSCOT DR CITY: REDWOOD CITY STATE: CA ZIP: 94063 15-12G 1 y7380915e15v12g.htm FORM 15-12G FORM 15-12G
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 0-19222
GENELABS TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
505 Penobscot Drive, Redwood City, CA 94063, (650) 369-9500
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Common Stock, no par value
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
     Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
     
Rule 12g-4(a)(1)
  þ
Rule 12g-4(a)(2)
  o
Rule 12h-3(b)(1)(i)
  þ
Rule 12h-3(b)(1)(ii)
  o
Rule 15d-6
  o
     Approximate number of holders of record as of the certification or notice date: One (1)
     Pursuant to the requirements of the Securities Exchange Act of 1934, Genelabs Technologies, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
         
Date: January 20, 2009
  By:   /s/ Audrey Klijian
 
       
 
  Name:   Audrey Klijian
 
  Title:   Chief Financial Officer
 
 

 -----END PRIVACY-ENHANCED MESSAGE-----